Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  AMAG Pharmaceuticals, Inc.    AMAG

AMAG PHARMACEUTICALS, INC. (AMAG)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/17/2018 04/18/2018 04/19/2018 04/20/2018 04/23/2018 Date
21.25(c) 20.8(c) 19.85(c) 19.35(c) 19.7(c) Last
578 821 386 212 567 879 527 492 604 875 Volume
+1.43% -2.12% -4.57% -2.52% +1.81% Change
More quotes
Financials (USD)
Sales 2018 544 M
EBIT 2018 -83,4 M
Net income 2018 -138 M
Debt 2018 524 M
Yield 2018 -
Sales 2019 497 M
EBIT 2019 -48,7 M
Net income 2019 -83,6 M
Debt 2019 591 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 2,17x
EV / Sales2019 2,52x
Capitalization 660 M
More Financials
Company
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia.It focuses on the development and commercialization of Feraheme injection for intravenous or IV, use to treat iron... 
Sector
Pharmaceuticals
Calendar
05/03 | 10:30amEarnings Call
More about the company
Surperformance© ratings of AMAG Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on AMAG PHARMACEUTICALS, INC.
04/04AMAG PHARMACEUTICALS : Kathryn Payne Joins MassBio Board of Directors
AQ
03/30PALATIN TECHNOLOGIES : Announces Submission of Bremelanotide NDA to FDA for Trea..
AQ
03/29AMAG PHARMACEUTICALS : Submits a New Drug Application to the U.S. Food and Drug ..
AQ
03/27AMAG PHARMACEUTICALS : Submits a New Drug Application to the U.S. Food and Drug ..
AQ
03/27PALATIN TECHNOLOGIES : Announces Submission of Bremelanotide NDA to FDA for Trea..
AQ
03/26AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug..
GL
03/23AMAG PHARMACEUTICALS,INC. (NASDAQ : AMAG) Files An 8-K Regulation FD Disclosure
AQ
03/23AMAG PHARMACEUTICALS INC. : Regulation FD Disclosure (form 8-K)
AQ
03/16ANTARES PHARMA : Reports Fourth Quarter and Full Year 2017 Operating and Financi..
AQ
03/09AMAG PHARMACEUTICALS : to Present at Upcoming Investor Conferences
AQ
More news
Sector news : Pharmaceuticals - NEC
11:35aSANOFI'S VALPROATE RESTRICTED FOR SO : Regulator
DJ
10:32aSANOFI : UK bans Sanofi epilepsy drug without pregnancy prevention plan
RE
09:28aCircassia 2017 Pretax Loss Narrows; AstraZeneca Increases Stake
DJ
08:56aASTRAZENECA : Negative Results From Phase 3 Trial of Imfinzi and Tremelimumab
DJ
08:37aASTRAZENECA : to raise stake in Circassia to up to 19.9 percent
RE
More sector news : Pharmaceuticals - NEC
Latest Tweets
07:43aAMAG Pharmaceuticals $AMAG Downgraded to Hold at BidaskClub  
04/21BidaskClub Lowers AMAG Pharmaceuticals $AMAG to Hold  
04/20AMAG Pharmaceuticals, Inc. $AMAG Expected to Announce Earnings of -$0.49 Per .. 
04/19TREND REVERSAL DOWN ALERT: $AMAG AMAG PHARMACEUTICALS ? TradeIdeas via  
04/18AMAG Pharmaceuticals, Inc. $AMAG Expected to Post Earnings of -$0.49 Per Shar.. 
More tweets
Qtime:60
News from SeekingAlpha
01:09aLooking For Action? S&P 1500 Most Volatile Stocks 
04/09READER INQUIRY : Antares Pharma PDUFA Date In September, Is Stock A Buy Here? 
04/05BY THE NUMBERS : Best Biotech Stocks 
03/29Looking For Action? S&P 1500 Most Volatile Stocks 
03/28AMAG Pharmaceuticals (AMAG) Presents At Needham And Company 17th Annual Healt.. 
Chart AMAG PHARMACEUTICALS, INC.
Duration : Period :
AMAG Pharmaceuticals, Inc. Technical Analysis Chart | AMAG | US00163U1060 | 4-Traders
Technical analysis trends AMAG PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 20,8 $
Spread / Average Target 5,5%
EPS Revisions
Managers
NameTitle
William K. Heiden President, Chief Executive Officer & Director
Gino Santini Chairman
Edward H. Myles Chief Financial Officer, Treasurer & Senior VP
Julie Krop Chief Medical Officer & SVP-Regulatory Affairs
Nathan McBride Chief Information Officer & Senior VP-Innovation
Sector and Competitors
1st jan.Capitalization (M$)
AMAG PHARMACEUTICALS, INC.46.04%660
JOHNSON & JOHNSON-9.23%339 783
PFIZER1.13%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%192 109
MERCK AND COMPANY7.07%158 571